References
- Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612-618. https://doi.org/10.1200/JCO.2005.04.1384
- Jo JC, Yoon DH, Kim S, et al. Clinical features and prognostic model for extranasal NK/T-cell lymphoma. Eur J Haematol 2012;89:103-110. https://doi.org/10.1111/j.1600-0609.2012.01796.x
- Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009;113:3931-3937. https://doi.org/10.1182/blood-2008-10-185256
- Kwong YL, Kim WS, Lim ST, et al. SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood 2012;120:2973-2980. https://doi.org/10.1182/blood-2012-05-431460
- Lee J, Au WY, Park MJ, et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant 2008;14:1356-1364. https://doi.org/10.1016/j.bbmt.2008.09.014
Cited by
- Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases vol.11, pp.6, 2015, https://doi.org/10.1007/s11899-016-0355-9
- Clinical characteristics and treatment of 69 patients with extranodal natural killer T-cell lymphoma vol.5, pp.6, 2015, https://doi.org/10.3892/mco.2016.1067